These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 23747144

  • 1. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA.
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [Abstract] [Full Text] [Related]

  • 2. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [Abstract] [Full Text] [Related]

  • 4. Increasing the donor pool reduces the severity of liver disease: lessons learned from São Paulo, Brazil.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2286-8. PubMed ID: 23026575
    [Abstract] [Full Text] [Related]

  • 5. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.
    Ann Hepatol; 2013 Oct; 12(3):440-7. PubMed ID: 23619261
    [Abstract] [Full Text] [Related]

  • 6. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [Abstract] [Full Text] [Related]

  • 7. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [Abstract] [Full Text] [Related]

  • 8. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
    Samuel D, Colombo M, El-Serag H, Sobesky R, Heaton N.
    Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
    [Abstract] [Full Text] [Related]

  • 9. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
    Herden U, Grabhorn E, Briem-Richter A, Ganschow R, Nashan B, Fischer L.
    Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
    [Abstract] [Full Text] [Related]

  • 10. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F, Coria SA, Boni R, Pereira LA.
    Transplant Proc; 2009 Sep; 41(1):226-8. PubMed ID: 19249520
    [Abstract] [Full Text] [Related]

  • 11. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [Abstract] [Full Text] [Related]

  • 12. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 13. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR, Ferguson N, Cannon RM, Jones CM, Brock GN.
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [Abstract] [Full Text] [Related]

  • 14. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 15. Impact of model for end-stage liver disease score on long-term survival following liver transplantation for hepatocellular carcinoma.
    Roma J, Balbi E, Pacheco-Moreira L, Zyngier I, Araujo A, Agoglia L, Steinbruck K, Velaverde LG, Martinho JM.
    Transplant Proc; 2012 Oct; 44(8):2423-7. PubMed ID: 23026611
    [Abstract] [Full Text] [Related]

  • 16. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
    Berry K, Ioannou GN.
    Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
    [Abstract] [Full Text] [Related]

  • 18. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.
    Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT.
    Liver Transpl; 2004 Jan; 10(1):42-8. PubMed ID: 14755776
    [Abstract] [Full Text] [Related]

  • 19. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.